Niagen Bioscience (NAGE) Leases (2019 - 2025)
Niagen Bioscience (NAGE) has disclosed Leases for 7 consecutive years, with $2.2 million as the latest value for Q4 2025.
- On a quarterly basis, Leases rose 26.71% to $2.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 million, a 26.71% increase, with the full-year FY2025 number at $2.2 million, up 26.71% from a year prior.
- Leases was $2.2 million for Q4 2025 at Niagen Bioscience, down from $2.4 million in the prior quarter.
- In the past five years, Leases ranged from a high of $4.4 million in Q4 2021 to a low of $1.7 million in Q4 2024.
- A 5-year average of $2.9 million and a median of $3.0 million in 2023 define the central range for Leases.
- Peak YoY movement for Leases: skyrocketed 353.9% in 2021, then tumbled 36.67% in 2024.
- Niagen Bioscience's Leases stood at $4.4 million in 2021, then fell by 20.45% to $3.5 million in 2022, then tumbled by 31.43% to $2.4 million in 2023, then dropped by 27.92% to $1.7 million in 2024, then grew by 26.71% to $2.2 million in 2025.
- Per Business Quant, the three most recent readings for NAGE's Leases are $2.2 million (Q4 2025), $2.4 million (Q3 2025), and $2.5 million (Q2 2025).